Who is sponsoring NCT05069532?

NCT05069532 is sponsored by Assiut University.

What drugs are being tested in NCT05069532?

Interventions in NCT05069532: MSCT chest, PCR.

What condition does NCT05069532 study?

NCT05069532 studies COVID-19 Infection in Hemodialysis Patients.

Is NCT05069532 still recruiting?

NCT05069532 is currently status unknown. Last updated 6 October 2021.

Last reviewed 2021-10-06 · How we verify

NCT05069532

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19 Infection in Hemodialysis Patients

Status unknown Last updated 6 October 2021

What this trial tests

trial testing MSCT chest in COVID-19 Infection in Hemodialysis Patients in 100 participants. Status unknown.

Timeline

1 October 2021

Primary endpoint
30 September 2022

31 March 2023

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 October 2021
Primary completion	30 September 2022
Estimated completion	31 March 2023

Drugs / interventions tested

MSCT chest
PCR

Conditions studied

COVID-19 Infection in Hemodialysis Patients — all drugs for COVID-19 Infection in Hemodialysis Patients →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with COVID-19 Infection in Hemodialysis Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dialysis patients have a higher risk of infectious complications including complications from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which causes COVID-19. There have been several reports describing the effect of CO¬VID-19 in the dialysis population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05069532 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 6 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05069532.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing